Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-08, Stock:LLY, The news for the past five days is as follows:
2018-11-01: NEWS1: Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View.NEWS2: Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View.NEWS3: Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales.NEWS4: Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales.NEWS5: Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates &apos;18 View.NEWS6: Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript.NEWS7: United Therapeutics (UTHR) Q3 Earnings Beat but Stock Dips.NEWS8: Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises '18 View.NEWS9: Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises '18 View.NEWS10: Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?.NEWS11: Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?.NEWS12: Eli Lilly (LLY) to Report Q3 Earnings: What&apos;s in the Cards?.NEWS13: Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises &apos;18 View.NEWS14: 3 Pharma Stocks to Make a Portfolio Feel Better.NEWS15: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS16: Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure.NEWS17: Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure.NEWS18: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS19: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.
2018-11-02: NEWS1: AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues.NEWS2: AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues.NEWS3: AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues.NEWS4: Earnings Estimates Coming Down.NEWS5: Earnings Estimates Coming Down.NEWS6: Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss.NEWS7: Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss.NEWS8: Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise.NEWS9: Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise.NEWS10: A Look at Merck’s Diabetes and Women’s Health Business.NEWS11: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.NEWS12: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.NEWS13: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.
2018-11-05: NEWS1: Berkshire Hathaway and Lilly climb; Sysco and MGM sink.NEWS2: Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3.NEWS3: Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3.NEWS4: Health Care Sector Update for 11/05/2018: LLY,BHC,BTAI,FOLD.NEWS5: Health Care Sector Update for 11/05/2018: LLY,BHC,BTAI,FOLD.NEWS6: Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines.NEWS7: Pre-Market Earnings Report for November 6, 2018 :  LLY, CVS, BDX, EMR, REGN, APD, TRI, ADM, ABC, TDG, BR, HSIC.NEWS8: Pre-Market Earnings Report for November 6, 2018 :  LLY, CVS, BDX, EMR, REGN, APD, TRI, ADM, ABC, TDG, BR, HSIC.NEWS9: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS10: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS11: Health care companies and banks climb; Apple falls.NEWS12: Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3.NEWS13: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS14: US stocks rise as Berkshire climbs; Apple sinks again.NEWS15: How Wall Street Analysts View Teva Pharmaceutical.NEWS16: US stocks are higher as Berkshire climbs; Apple sinks again.NEWS17: Eli Lilly Gets Ready For First Report Post-Elanco IPO.NEWS18: Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes.NEWS19: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS20: Disney, Michael Kors, Ralph Lauren and Eli Lilly are part of Zacks Earnings Preview.NEWS21: Disney, Michael Kors, Ralph Lauren and Eli Lilly are part of Zacks Earnings Preview.NEWS22: Disney, Michael Kors, Ralph Lauren and Eli Lilly are part of Zacks Earnings Preview.NEWS23: Top 5 Things to Know in The Market on Monday.NEWS24: Lilly says diabetes drug Trulicity reduces heart risks in trial.NEWS25: Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes.NEWS26: Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease.NEWS27: Eli Lilly: REWIND Trial Demonstrates MACE Reduction By Trulicity - Quick Facts.NEWS28: Eli Lilly: REWIND Trial Demonstrates MACE Reduction By Trulicity - Quick Facts.
2018-11-06: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: Stocks - Dow Rallies as Midterm Mania Grips Wall Street.NEWS4: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS5: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS6: Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release.NEWS7: The midterm election could decide the fate of these three health-care groups.NEWS8: What Happened in the Stock Market Today.NEWS9: Mallinckrodt Pops On Quarter Beat As Lilly Dips On Mixed Report.NEWS10: Nasdaq Gains for First Day in Three as U.S. Voters Head to the Polls.NEWS11: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS12: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS13: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS14: MarketPulse: Mylan Surges to Keep Health Care Stocks Well Above Flatline.NEWS15: Eli Lilly's Conservative Pricing Offers Protection From Political Pressure.NEWS16: Eli Lilly's Elanco Offload Offers Acquisition Flexibility.NEWS17: Buy Eli Lilly on the pullback? Why isn't Southwest taking....NEWS18: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS19: Eli Lilly Tops Q3 Earnings Estimate, Lifts 2018 Outlook as Diabetes Sales Rise.NEWS20: Mid-Day Update: Wall Street Grinds Higher as Americans Go To the Polls.NEWS21: Mid-Day Update: Wall Street Grinds Higher as Americans Go To the Polls.NEWS22: Stocks Rise in Cautious Trading as America Heads to the Polls.NEWS23: September JOLTS Report In Spotlight.NEWS24: September JOLTS Report In Spotlight.NEWS25: Trulicity leads mixed third quarter for Lilly; shares sink.NEWS26: Eli Lilly’s Big Picture Justifies Its Lofty Valuation.NEWS27: Wall Street Continues to See Opportunity in Eli Lilly.NEWS28: 2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks.NEWS29: Stocks - Wall Street Rises After Upbeat Earnings.NEWS30: Trulicity leads mixed third quarter for Lilly; shares sink.NEWS31: September JOLTS Report In Spotlight.NEWS32: Lilly (LLY) Tops Q3 Earnings, Lifts 2018 Outlook, Stock Up.NEWS33: Tech Stocks Lead Stock Market Rally As Facebook Suspends More Accounts.NEWS34: Stocks Rise Slightly in Cautious Trading as America Heads to the Polls.NEWS35: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS36: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS37: Eli Lilly Offers Healthy Outlook to Kick Off November.NEWS38: Lilly to consider more acquisitions like $1.6 billion Armo buy.NEWS39: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS40: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS41: Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains.NEWS42: Eli Lilly Earnings, Revenue beat in Q3.NEWS43: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS44: [$$] Eli Lilly Raises 2018 Guidance after Strong 3Q.NEWS45: Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & more.NEWS46: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS47: Top 5 Things to Know in The Market on Tuesday.NEWS48: Eli Lilly CEO on earnings and drug pricing.NEWS49: Should You Buy Paypal Holdings Inc (PYPL)?.NEWS50: The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering.NEWS51: Today's Research Reports on Trending Tickers: GlaxoSmithKline and Eli Lilly and Company.NEWS52: Earnings Reaction History: Eli Lilly & Co., 45.5% Follow-Through Indicator, 2.7% Sensitive.NEWS53: Earnings Reaction History: Eli Lilly & Co., 45.5% Follow-Through Indicator, 2.7% Sensitive.NEWS54: Lilly: 3Q Earnings Snapshot.NEWS55: Eli Lilly beats earnings expectations, raises guidance.NEWS56: Eli Lilly posts top and bottom line beats.NEWS57: Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance.NEWS58: Eli Lilly And Co. Q3 18 Earnings Conference Call At 9:00 AM ET.NEWS59: Eli Lilly And Co. Q3 18 Earnings Conference Call At 9:00 AM ET.NEWS60: Eli Lilly Q3 Results Beat View; Lifts FY18 Outlook.NEWS61: Eli Lilly Q3 Results Beat View; Lifts FY18 Outlook.NEWS62: Asian shares meander, oil lower ahead of US midterms vote.
2018-11-07: NEWS1: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS2: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS3: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS4: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS5: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS6: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS7: What AbbVie’s Bottom Line Trend Indicates.NEWS8: A Look at AbbVie’s Operational Performance.NEWS9: How AbbVie Is Positioned in November.NEWS10: Drug Stocks Climb as Investors Digest Midterm Election Results.NEWS11: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS12: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS13: Noteworthy ETF Outflows: XLV, AMGN, MDT, LLY.NEWS14: Noteworthy ETF Outflows: XLV, AMGN, MDT, LLY.NEWS15: Sanofi Eczema Drug Dupixent's sBLA Gets Priority Review.NEWS16: Sanofi Eczema Drug Dupixent's sBLA Gets Priority Review.NEWS17: Edited Transcript of LLY earnings conference call or presentation 6-Nov-18 2:00pm GMT.

Answer: Rise